Table 2.
NI normal | coMO normal | sox4bMO absence | sox4bMO decrease | |
---|---|---|---|---|
Embryo, 48 hpf | ||||
tshβ | 10/10 | 89/100 | 12/122 | 110/122a |
gsuα | 10/10 | 38/40 | 0/38 | 38/38a |
glucagon | 10/10 | 70/78 | 0/78 | 78/78a |
slβ | 8/10 | 38/40 | 5/40 | 0/40 |
pomc | 10/10 | 40/40 | 0/40 | 0/40 |
lim3 | 10/10 | 38/38 | 2/40 | 0/40 |
pit1 | 10/10 | 27/27 | 0/35 | 0/35 |
gata2a | 10/10 | 40/40 | 38/40a | 0/40 |
gh | 9/10 | 45/45 | 0/58 | 48/58a |
prl | 10/10 | 50/50 | 0/50 | 0/50 |
Larvae, 4 dpf | ||||
lhβ | 10/10 | 50/50 | 0/50 | 28/50 |
tshβ | 10/10 | 50/50 | 12/50a | 15/50a |
gsuα | 10/10 | 50/50 | 0/50 | 30/50a |
gh | 10/10 | 50/50 | 0/50 | 25/50a |
prl | 10/10 | 50/50 | 0/50 | 0/50 |
Individual embryos, previously noninjected (NI) or injected with coMO or sox4bMO, were optically analyzed and compared for expression of different marker genes at 48 hpf and 4 dpf. The embryos were classified according to phenotype, and the number of each class is given relative to the total number of analyzed embryos for each condition. Absence indicates lost expression; decrease indicates that marker expression was reduced by more than 50%.
Significant at P < 0.001.